Miras, Alecia Faith R.
HRN: 20-55-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/30/2023
05/06/2023
PO
1ml
QID
T/c Hand Foot Mouth Disease
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & MouthProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes